Use of ultrasound to predict and optimize outcomes of ovulation induction

Infertility and Reproductive Medicine Clinics of North America

Volumn 14, Issue 2, 2003, Pages 269-291

  Syrop, Craig H ^a   Van Voorhis, Brad ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; DIETHYLSTILBESTROL; ESTRADIOL; ETHINYLESTRADIOL; GONADORELIN AGONIST; LETROZOLE; ORAL CONTRACEPTIVE AGENT;

ENDOMETRIUM; HUMAN; LAPAROSCOPY; OOCYTE; OVARY; OVULATION; OVULATION INDUCTION; REVIEW; TRANSVAGINAL ECHOGRAPHY; ULTRASOUND; UTERINE ARTERY; UTERUS;

EID: 0037686622     PISSN: 10479422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Pavlik EJ, DePriest PD, Gallion HH, et al. Ovarian volume related to age. Gynecol Oncol 2000;77:410-2.
2. Christensen JT, Boldsen J, Westergaard JG. Ovarian volume in gynecologically healthy women using no contraception, or using IUD or oral contraception. Acta Obstet Gynecol Scand 1997;76:784-9.
3. Flaws JA, Langenberg P, Babus JK, et al. Ovarian volume and antral follicle counts as indicators of menopausal status. Menopause 2001;8:175-80.
4. Syrop CH, Willhoite A, Van Voorhis BJ. Ovarian volume: a novel outcome predictor for assisted reproduction. Fertil Steril 1995;64:1167-71.
5. Syrop CH, Dawson JD, Husman KJ, et al. Ovarian volume may predict assisted reproductive outcomes better than follicle stimulating hormone concentration on day 3. Hum Reprod 1999;14:1752-6.
6. Lass A, Skull J, McVeigh E, et al. Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotrophin for in-vitro fertilization can predict poor response. Hum Reprod 1997;12:294-7.
7. Tomas C, Nuojua-Huttunen S, Martikainen H. Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro fertilization. Hum Reprod 1997;12:220-3.
8. Sharara FI, McClamrock HD. Use of microdose GnRH agonist protocol in women with low ovarian volumes undergoing IVF. Hum Reprod 2001;16:500-3.
9. Sharara FI, Lim J, McClamrock HD. The effect of pituitary desensitization on ovarian volume measurements prior to in-vitro fertilization. Hum Reprod 1999;14:183-5.
10. Sharara FI, McClamrock HD. The effect of aging on ovarian volume measurements in infertile women. Obstet Gynecol 1999;94:57-60.
11. Ruess ML, Kline J, Santos R, et al. Age and the ovarian follicle pool assessed with transvaginal ultrasonography. Am J Obstet Gynecol 1996;174:624-7.
12. Scheffer GJ, Broekmans FJM, Dorland M, et al. Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertil Steril 1999;72:845-51.
13. Frattarelli JL, Lauria-Costa DF, Miller BT, et al. Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles. Fertil Steril 2000;74:512-7.
14. Bancsi LF, Broekmans FJM, Eijkemans MJC, et al. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril 2002;77:328-36.
15. Kyei-Mensah A, Pittrof R, Maconochie N, et al. Transvaginal three-dimensional ultrasound: reproducibility of ovarian and endometrial volume measurements. Fertil Steril 1996;66:718-22.
16. Pellicer A, Ardiles G, Neuspiller F, et al. Evaluation of the ovarian reserve in young low responders with normal basal levels of follicle-stimulating hormone using three-dimensional ultrasonography. Ferfil Steril 1998;70:671-5.
17. Schild RL, Knobloch C, Dorn C, et al. The role of ovarian volume in an in vitro fertilization programme as assessed by 3D ultrasound. Arch Gynecol Obstet 2001;265:67-72.
18. Dumesic DA, Damario MA, Session DR, et al. Ovarian morphology and serum hormone markers as predictors of ovarian follicle recruitment by gonadotropins for in vitro fertilization. J Clin Endocrinol Metab 2001;86:2538-43.
19. Hammadieh N, Afnan M, Papaaioannou S, et al. Women with small ovarian volume and microdose GnRH agonist protocol [letter]. Hum Reprod 2001;16:2030.
20. Danniger B, Brunner M, Obruca A, et al. Prediction of ovarian hyperstimulation syndrome of baseline ovarian volume prior to stimulation. Hum Reprod 1996;11:1597-9.
21. Huang F-J, Chang S-Y, Tsai M-Y, et al. Determination of the efficiency of controlled ovarian hyperstimulation in the gonadotropin-releasing hormone agonist-suppression cycle using the initial follicle count during gonadotropin stimulation. J Assist Reprod Genet 2001;18:91-6.
22. Wittmaack FM, Tureck RW, Kreger DO, et al. Effect of follicular size on oocyte retrieval, fertilization, cleavage, and embryo quality in in vitro fertilization cycles: a 6-year data collection. Fertil Steril 1994;62:1205-10.
23. Andersen CY. Characteristics of human follicular fluid associated with successful conception after in vitro fertilization. J Clin Endocrinol Metab 1993;77:1227-34.
24. Bergh C, Broden H, Lundin K, et al. Comparison of fertilization, cleavage and pregnancy rates of oocytes from large and small follicles. Hum Reprod 1998;13:1912-5.
25. Miller KF, Goldberg JM, Falcone T. Follicle size and implantation of embryos from in vitro fertilization. Obstet Gynecol 1996;88:583-6.
26. Chui DKC, Pugh ND, Walker SM, et al. Follicular vascularity - the predictive value of transvaginal power Doppler ultrasonography in an in-vitro fertilization programme: a preliminary study. Hum Reprod 1997;12:191-6.
27. Bhal PS, Pugh ND, Chui DK, et al. The use of transvaginal power Doppler ultrasonography to evaluate the relationship between perifollicular vascularity and outcome in in-vitro fertilization treatment cycles. Hum Reprod 1999;14:939-45.
28. Borini A, Maccolini A, Tallarini A, et al. Perifollicular vascularity and its relationship with oocyte maturity and IVF outcome. Ann NY Acad Sci 2001;943:64-7.
29. De Geyter C, Schmitter M, De Geyter M, et al. Prospective evaluation of the ultrasound appearance of the endometrium in a cohort of 1,186 infertile women. Fertil Steril 2000;73:106-13.
30. Noyes N, Liu H-C, Sultan K, et al. Endometrial thickness appears to be a significant factor in embryo implantation in in-vitro fertilization. Hum Reprod 1995;10:919-22.
31. Sher G, Herbert C, Maassarani G, et al. Assessment of the late proliferative phase endometrium by ultrasonography in patients undergoing in-vitro fertilization and embryo transfer (IVF/ET). Hum Reprod 1991;6:232-7.
32. Sharara FI, Lim J, McClamrock HD. Endometrial pattern on the day of oocyte retrieval is more predictive of implantation success than the pattern or thickness on the day of hCG administration. J Assist Reprod Genet 1999;16:523-8.
33. Ueno J, Oehminger S, Bryzski R, et al. Ultrasonographic appearance of the endometrium in natural and stimulated in-vitro fertilization cycles and its correlation with outcome. Hum Reprod 1991;6:901-4.
34. Dickey RP, Curole DN, Olar TT, et al. Relationship of endometrial thickness and pattern to fecundity in ovulation induction cycles: effect of clomiphene citrate alone and with human menopausal gonadotropin. Fertil Steril 1993;59:756-60.
35. Spandorfer SD, Arrandondo-Soberon F, Loret de Mola JR, et al. Reliability of intraobserver and interobserver sonographic endometrial stripe thickness measurements. Fertil Steril 1998;70:152-4.
36. Friedler S, Schenker JG, Herman A, et al. The role of ultrasonography in the evaluation of endometrial receptivity following assisted reproductive treatments: a critical review. Hum Reprod 1996;2:323-35.
37. Gonen Y, Casper RF, Jacobson W, et al. Endometrial thickness and growth during ovarian stimulation: a possible predictor of implantation in in vitro fertilization. Fertil Steril 1989;52:446-50.
38. Gonen Y, Casper RF. Prediction of implantation by the sonographic appearance of the endometrium during controlled ovarian stimulation for in vitro fertilization (IVF). J In Vitro Fertil Embryo Transf 1990;7:146-52.
39. Coulam CB, Bustillo M, Soenksen DM, et al. Ultrasonographic predictors of implantation after assisted reproduction. Fertil Steril 1994;62:1004-10.
40. Sundstrom P. Establishment of a successful pregnancy following in vitro fertilization with an endometrial thickness of no more than 4 mm. Hum Reprod 1998;10:1550-2.
41. Sher G, Dodge S, Massarani G, et al. Management of suboptimal sonographic endometrial patterns in patients undergoing in vitro fertilization and embryo transfer. Hum Reprod 1993;8:347-9.
42. Weissman A, Gotleib L, Casper RF. The detrimental effect of increased endometrial thickness on implantation and pregnancy rates and outcome in an in vitro fertilization program. Fertil Steril 1999;71:81-3.
43. Kupesic S, Bekavac I, Bjelos D, et al. Assessment of endometrial receptivity by transvaginal color Doppler and three-dimensional power Doppler ultrasonography in patients undergoing in vitro fertilization procedures. J Ultrasound Med 2001;20:125-34.
44. Schild RL, Indefrei D, Eschweiler S, et al. Three-dimensional endometrial volume calculation in an in-vitro fertilization programme. Hum Reprod 1999;14:1255-8.
45. Dietterich C, Check JH, Choe JK, et al. Increased endometrial thickness on the day of human chorionic gonadotropin injections does not adversely affect pregnancy or implantation rates following in vitro fertilization-embryo transfer. Fertil Steril 2002;77:781-6.
46. Fanchin R. Assessing uterine receptivity in 2001. Ultrasonographic glances at the new millennium. Ann NY Acad Sci 2001;943:185-202.
47. Schild RL, Knobloch C, Dorn C, et al. Endometrial receptivity in an in vitro fertilization program as assessed by spiral artery blood flow, endometrial thickness, endometrial volume and uterine artery blood flow. Fertil Steril 2001;75:361-6.
48. Noyes N, Hampton BS, Berkeley A, et al. Factors useful in predicting the success of oocyte donation: a 3-year retrospective analysis. Fertil Steril 2001;76:92-7.
49. Remohi J, Ardiles G, Garcia-Velasco JA, et al. Endometrial thickness and serum oestradiol concentrations as predictors of outcome in oocyte donation. Hum Reprod 1997;12:2271-6.
50. Sher G, Fisch JD. Vaginal sildenafil (Viagra): a preliminary report of a novel method to improve uterine artery blood flow and endometrial development in patients undergoing IVF. Hum Reprod 2000;15:806-9.
51. Rubinstein M, Marazzi A, de Fried EP. Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay. Fertil Steril 1999;71:825-9.
52. Fleischer AC, Pittaway DE, Beard LA, et al. Sonographic depiction of endometrial changes occurring with ovulation induction. J Ultrasound Med 1984;3:341.
53. Randall JM, Templeton A. Transvaginal sonographic assessment of follicular and endometrial growth in spontaneous and clomiphene citrate cycles. Fertil Steril 1991;56:208.
54. Sereepapong W, Suwajankom S, Triratanachat S, et al. Effects of clomiphene citrate on the endometrium of regularly cycling women. Fertil Steril 2000;73:287-91.
55. Nakamura Y, Sugino N, Ono M, et al. Effects of clomiphene citrate on the endometrial thickness and echogenic pattern of the endometrium. Fertil Steril 1997;67:256-60.
56. Hock DL, Bohrer MK, Ananth CV, et al. Sonographic assessment of endometrial pattern and thickness in patients treated with clomiphene citrate, human menopausal gonadotropins and intrauterine insemination. Fertil Steril 1997;68:242-5.
57. Shimoya K, Tomiyama T, Hashimoto K, et al. Endometrial development was improved by transdermal estradiol in patients treated with clomiphene citrate. Gynecol Obstet Invest 1999;47:251-4.
58. Unfer V, Costabile L, Gerli S, et al. Low dose of ethinyl estradiol can reverse the antiestrogenic effect of clomiphene citrate on endometrium. Gynecol Obstet Invest 2001;51:120-3.
59. Mitwally MFM, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 2001;75:305-9.
60. Boostanfar R, Jain JK, Miiswhell DR, et al. A prospective randomized trail comparing clomiphene citrate and tamoxifen citrate for ovulation induction. Fertil Steril 2001;75:1024-6.